** Ebiogen Discusses Expanded Global Collaboration with Singapore-Based Germonizer **
2026-07-09
본문
Ebiogen Inc. welcomed executives from Germonizer Pte Ltd, a Singapore-based company, to its Seoul headquarters on July 8, 2026, for a business meeting to discuss potential areas of strategic collaboration.
During the meeting, both companies explored a broad range of opportunities, including product supply cooperation for Ebiogen’s house dust mite detection kit and bed bug detection kit, as well as potential collaboration in NGS-based genomic analysis services. The two companies agreed that combining Ebiogen’s diagnostic product development and genomic analysis capabilities with Germonizer’s market network and business development experience could create meaningful synergies, and decided to further review mutually beneficial cooperation opportunities.
Germonizer is a Singapore-based company that provides specialized solutions across healthcare, drug testing, CBRNE detection, and forensic investigation fields. With its established business network in Singapore and other international markets, Germonizer is expected to serve as a valuable partner for expanding the global reach of Ebiogen’s rapid detection kits and genomic analysis services.
Through this discussion, Ebiogen aims to broaden the international supply opportunities for its house dust mite and bed bug detection kits while strengthening overseas partnerships in the field of NGS services. Moving forward, both companies plan to explore practical collaboration models in product supply, market development, and technology-based service linkage, with the shared goal of creating sustainable value and expanding their presence in global markets.